Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.
https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png00https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png2022-04-18 23:50:052022-04-18 23:50:05Scientists Question Data Behind an Experimental Alzheimer’s Drug
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.